A detailed history of Glen Eagle Advisors, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 442 shares of DGX stock, worth $60,593. This represents 0.01% of its overall portfolio holdings.

Number of Shares
442
Previous 400 10.5%
Holding current value
$60,593
Previous $40.1 Million 50.8%
% of portfolio
0.01%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $5,288 - $6,062
42 Added 10.5%
442 $60.5 Million
Q1 2024

Jul 03, 2024

BUY
$123.78 - $142.11 $54,710 - $62,812
442 New
442 $58.8 Million
Q4 2022

Aug 13, 2024

SELL
$123.31 - $157.26 $4,932 - $6,290
-40 Reduced 8.3%
442 $69.1 Million
Q1 2022

Aug 13, 2024

BUY
$129.09 - $164.35 $5,163 - $6,574
40 Added 9.05%
482 $66 Million
Q3 2019

Aug 13, 2024

BUY
$97.85 - $107.42 $97 - $107
1 Added 0.23%
442 $47.3 Million
Q2 2019

Aug 13, 2024

BUY
$85.18 - $101.94 $3,492 - $4,179
41 Added 10.25%
441 $44.9 Million
Q1 2019

Aug 13, 2024

SELL
$80.68 - $89.92 $3,388 - $3,776
-42 Reduced 9.5%
400 $36 Million
Q1 2018

Aug 14, 2024

SELL
$96.42 - $107.88 $4,049 - $4,530
-42 Reduced 9.5%
400 $40.1 Million
Q4 2017

Aug 13, 2024

SELL
$90.86 - $100.24 $13,356 - $14,735
-147 Reduced 26.87%
400 $39.4 Million
Q3 2017

Aug 13, 2024

BUY
$91.96 - $108.35 $9,655 - $11,376
105 Added 23.76%
547 $51.2 Million
Q2 2017

Aug 12, 2024

BUY
N/A
147 Added 36.75%
547 $60.8 Million
Q1 2017

Aug 12, 2024

SELL
N/A
-200 Reduced 33.33%
400 $39.3 Million
Q4 2016

Aug 12, 2024

BUY
N/A
158
600 $55.1 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.